Biosafety Cabinet Enhances User Experience - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Biosafety Cabinet Enhances User Experience


Labconco’s Purifier Logic+ cabinet uses Inclination Technology that goes beyond ergonomics to take into account the human body and human behavior and provide a more comfortable working environment. A full-color display provides user-friendly programming and feedback and is mounted to be in the user’s line of sight while seated. An electronically commutated motor (ECM) is more energy efficient, quieter, and generates less heat than conventional motors. The ECM also has greater torque that allows it to overcome resistance as filters load so filters last longer. Labconco’s Constant Airflow Profile technology works with the ECM to accurately maintain proper airflow without airflow sensors.

Source: Labconco

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here